These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 2111137)
41. [Do indications for transfusion of plasma still exist?]. Bins M; Russchen-Dekker AG; Siemons AW Ned Tijdschr Geneeskd; 1991 Sep; 135(37):1709. PubMed ID: 1922519 [No Abstract] [Full Text] [Related]
42. Preparation of high-purity factor VIII by controlled pore glass chromatography. Margolis J; Rhoades PH Lancet; 1981 Aug; 2(8244):446-9. PubMed ID: 6115204 [No Abstract] [Full Text] [Related]
45. Adoption of new methods for high-yield factor VIII recovery. Rock G Transfusion; 1989 Jun; 29(5):466-7. PubMed ID: 2499960 [No Abstract] [Full Text] [Related]
46. Factor VIII supply and demand. Br Med J; 1980 Oct; 281(6246):1006. PubMed ID: 6775753 [No Abstract] [Full Text] [Related]
47. Factor VIII supply and demand. Aronstam A Br Med J; 1980 Sep; 281(6243):810. PubMed ID: 6775750 [No Abstract] [Full Text] [Related]
48. Approaches to plasma fractionation for improved recovery and the development of potentially useful clinical factors. Johnson AJ; Mathews RW; Fulton AJ Clin Haematol; 1984 Feb; 13(1):3-15. PubMed ID: 6426834 [TBL] [Abstract][Full Text] [Related]
51. Plasma exchange donation of cryoprecipitate after DDAVP stimulation: an alternative source of factor VIII. McLeod BC; Scott JP Prog Clin Biol Res; 1990; 324():189-98. PubMed ID: 2106687 [TBL] [Abstract][Full Text] [Related]
52. Comparison of albumin, colloid osmotic pressure, von Willebrand factor, and coagulation factors in canine cryopoor plasma, cryoprecipitate, and fresh frozen plasma. Culler CA; Iazbik C; Guillaumin J J Vet Emerg Crit Care (San Antonio); 2017 Nov; 27(6):638-644. PubMed ID: 29064153 [TBL] [Abstract][Full Text] [Related]
53. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma. Caudill JS; Nichols WL; Plumhoff EA; Schulte SL; Winters JL; Gastineau DA; Rodriguez V Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257 [TBL] [Abstract][Full Text] [Related]
54. [Production of factor VIII preparations and their use in the substitution therapy of hemophilia A]. Gaerisch F; Stein P Z Gesamte Inn Med; 1982 Oct; 37(19):641-4. PubMed ID: 6817530 [TBL] [Abstract][Full Text] [Related]
55. [New aspects of blood component therapy]. Dettmann C; Weippert M; Roewer J; Wilms K Anaesthesiol Reanim; 1990; 15(2):87-93. PubMed ID: 2111137 [TBL] [Abstract][Full Text] [Related]